2m 2m 2m 2m 2m 2m 2m
ADMA Biologics (ADMA)
NASDAQ
$8.51+$0.05 (+0.59%)
Price as of Aug 03, 2026 7:29 AM EDT- $2.0BMarket Cap
- -56.23%1-Year Change
- BiotechnologyIndustry
ADMA Biologics (ADMA)
$8.51+$0.05 (+0.59%)
ADMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.46 | ||
Change | -$0.21 (-2.42%) | ||
Open | $8.58 | ||
High | $8.66 | ||
Low | $8.35 | ||
Previous Close | $8.67 | ||
Volume | 1,619,915 | ||
30-Day Average Volume | 2,579,953 | ||
1-Week Change | 2.30% | ||
1-Month Change | 1.08% | ||
1-Year Change | -56.23% | ||
3-Year Change | 103.86% | ||
5-Year Change | 445.81% | ||
Fundamentals | |||
Shares Outstanding | 231.8M | ||
Total Assets | $665.2M | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $114.5M | ||
Net Income | $45.3M | ||
Free Cash Flow | $55.7M | ||
EBIT | $57.1M | ||
EBITDA | $59.0M | ||
Net Working Capital | $437.6M | ||
EPS | $0.19 | ||
Enterprise Value/EBITDA | 34 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 5 | ||
P/E | 45 | ||
PEG | -6 | ||
Price/Free Cash Flow | 35 | ||
Price/Operating Cash Flow | 34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue